IMC Chicago’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-176,073
Closed -$46.7M 6879
2026
Q1
$19.3M Sell
176,073
-18,017
-9% -$2.57M 0.01% 881
2025
Q4
$32.3M Buy
194,090
+63,370
+48% +$10.6M 0.01% 645
2025
Q3
$25.6M Sell
130,720
-318
-0.2% -$52.3K 0.01% 682
2025
Q2
$11.8M Buy
131,038
+25,147
+24% +$1.99M 0.01% 947
2025
Q1
$6.32M Buy
105,891
+95,110
+882% +$8.8M ﹤0.01% 1104
2024
Q4
$1.43M Buy
+10,781
New +$1.01M ﹤0.01% 2113

Other funds holding ALAB

IMC Chicago's ALAB Position: Q2 2026 in Review

IMC Chicago sold out of Astera Labs (ALAB) in Q2 2026, closing a stake of 176,073 shares — an estimated $46.7M sold.

IMC Chicago first reported a position in ALAB in Q4 2024 and held it in 6 quarters. The position peaked at $32.3M in Q4 2025. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • IMC Chicago reported no remaining Astera Labs position as of Q2 2026 after selling out during the quarter.
  • IMC Chicago sold 176,073 Astera Labs shares in Q2 2026, an estimated $46.7M.
  • IMC Chicago first reported a position in Astera Labs in Q4 2024 and held it in 6 quarters.
  • IMC Chicago's Astera Labs position peaked at $32.3M in Q4 2025.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.